2-AMINOBENZAMIDE; Anthranilamide; 88-68-6; Benzamide, 2-amino-; o-Aminobenzamide; 2-Carbamoylaniline; Aminobenzamide; Anthranilimidic acid; Anthranilic acid amide; Benzamide, o-amino-; 2-Amino-Benzamide; Anthranilamide (VAN); o-Aminobenzamide (VAN); 2-Aminobenzamide (VAN); Anthranilimidic acid (VAN); Benzoic acid, 2-amino-, amide; 28144-70-9; MFCD00007981; Benzamide, o-amino- (VAN); 2-Aminobenzimidic acid; Q1M2WEK6VA; DTXSID2021789; NSC-38768; HSDB 5261; Benzenecarboximidicacid, 2-amino-; EINECS 201-851-2; UNII-Q1M2WEK6VA; NSC 38768; BRN 0508509; amino-benzamide; AI3-28018; o-carbamoylaniline; Oxytocin-d5; o-amino-benzamide; 2-aminobenz-amide; 2-Amino benzamide; ortho-aminobenzamide; 2AE; 2- amino-benzamide; 2-amino benzamide, 7; 2-aminobenzenecarboxamide; Anthranilamide, >=98%; AMINOBENZAMIDE, 2-; Oprea1_246280; SCHEMBL38228; 4-14-00-01010 (Beilstein Handbook Reference); MLS001066328; CHEMBL43175; 2-Amino-Benzamideanthranilamide; DTXCID501789; 2-AMINOBENZAMIDE [HSDB]; SCHEMBL11068162; BDBM33219; CHEBI:193638; HMS1732D11; HMS2269G08; ZINC152578; CS-D1680; NSC38768; STR02027; Tox21_200412; BBL012278; STL163592; Benzamide, o-amino- (VAN) (8CI); AKOS000119694; PS-5040; CAS-88-68-6; DISCONTINUED. Please see O878507; 2-Carbamoylaniline, Anthranilimidic acid; NCGC00247015-01; NCGC00247015-02; NCGC00257966-01; AC-20346; SMR000112353; SY001144; DB-022491; A0262; FT-0611226; EN300-17791; D71115; 2-Aminobenzamide 100 microg/mL in Acetonitrile; A842842; AT-057/40177776; W-100391; Q27286892; Z57036632; F3329-0460; Anthranilamide, matrix substance for MALDI-MS, >=99.0% (HPLC)